MoneyWorks4Me

Glenmark Pharmaceuticals informs about press release

23 Mar 2016 Evaluate

Glenmark Pharmaceuticals has informed about a Press Release dated March 23, 2016, titled ‘Glenmark Pharmaceuticals receives ANDA approval for Raloxifene Hydrochloride Tablets USP, 60 mg’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..